negative effects of glp 1 drugs GLP-1 Medications Infographic The promise and peril of
Description
Similar content being viewed by others Background Diabetic retinopathy (DR) is a common complication of diabetes mellitus [1], which in 2020 affected more than 100 million individuals worldwide
Kamrul-Hasan ABM, Hannan MA, Asaduzzaman M, Rahman MM, Alam MS, Amin MN, et al
J Cell Mol Med (2022) 26(3):65470
Adverse events were mostly mild-to-moderate gastrointestinal symptoms, consistent with other incretin-based therapies
n = 8613) groups
These gaps represent both clinical challenges requiring solutions and strategic opportunities for companies seeking differentiation in an increasingly crowded market
